Systematic and meta-analysis of Mycobacterium avium subsp. paratuberculosis related type 1 and type 2 diabetes mellitus

Abstract Global increase in diabetes (DM) prevalence necessitated the need to establish the association between DM and environmental triggers including MAP (Mycobacterium avium subsp. paratuberculosis) that have been postulated to play a role in DM etiopathology for effective management. The present...

Full description

Bibliographic Details
Main Authors: Temitope C. Ekundayo, Ayodeji O. Falade, Bright E. Igere, Chidozie D. Iwu, Mary A. Adewoyin, Tosin A. Olasehinde, Oluwatosin A. Ijabadeniyi
Format: Article
Language:English
Published: Nature Portfolio 2022-03-01
Series:Scientific Reports
Online Access:https://doi.org/10.1038/s41598-022-08700-4
_version_ 1818646809543704576
author Temitope C. Ekundayo
Ayodeji O. Falade
Bright E. Igere
Chidozie D. Iwu
Mary A. Adewoyin
Tosin A. Olasehinde
Oluwatosin A. Ijabadeniyi
author_facet Temitope C. Ekundayo
Ayodeji O. Falade
Bright E. Igere
Chidozie D. Iwu
Mary A. Adewoyin
Tosin A. Olasehinde
Oluwatosin A. Ijabadeniyi
author_sort Temitope C. Ekundayo
collection DOAJ
description Abstract Global increase in diabetes (DM) prevalence necessitated the need to establish the association between DM and environmental triggers including MAP (Mycobacterium avium subsp. paratuberculosis) that have been postulated to play a role in DM etiopathology for effective management. The present investigation aimed to assess the odds ratio (OR) presenting the association between MAP and DM. MAP-related DM studies were systematically retrieved from 6 databases until 31 September 2021 according to PRISMA principles for data abstraction. The abstracted dataset was fitted to the fixed-effects (FE) and random-effects (RE) models using the Mantel–Haenszel approach. Sixteen studies involving 2072 participants (1152 DM patients (957 type 1 diabetes mellitus (T1DM) & 195 type 2 diabetes mellitus (T2DM)) and 920 healthy controls) met the inclusion criteria. Results revealed a significant association between anti-MAP antibodies (abs) seroprevalence and T1DM (FE: OR 7.47, 95% CI 5.50–10.14, p value < 0.0001; RE: OR 7.92, 95% CI 4.39–14.31, p < 0.0001) and MAP DNA with T1DM (FE: OR 4.70 (95% CI 3.10–7.13, p value < 0.0001), RE: OR 3.90 (95% CI 0.93–16.38, p value = 0.06)). Both anti-MAP abs and MAP DNA based meta-analyses had medium heterogeneity (I2 = 47.2–61.0%). Meanwhile, no significant association between MAP and T2DM (FE: OR 1.13, 95% CI 0.54–2.37, p value = 0.74; RE: OR 1.19; 95% CI 0.34–4.12, p value = 0.69), its OR magnitude exceeded 1 and prediction interval (0.09–15.29) suggest possibility of association between the duo in the future. The leave-one-out sensitivity analysis depicts a robust meta-analysis in all cases. In conclusion, the study manifests a positive association between MAP and T1DM, highlighting that MAP prevention and environmental control would indubitably revolutionize T1DM management. Also, its projects possible link between MAP and T2DM as more data becomes available. However, it remains elusive whether MAP triggers T1/T2DM or a mere comorbidity in T1/T2DM. Epidemiological activities to fill the global/regional data gaps on MAP-related T1DM and T2DM are advocated in order to assess the burden of MAP-related DM and improve their clinical management.
first_indexed 2024-12-17T00:52:32Z
format Article
id doaj.art-beed324502c340b2bfb8af51783507d6
institution Directory Open Access Journal
issn 2045-2322
language English
last_indexed 2024-12-17T00:52:32Z
publishDate 2022-03-01
publisher Nature Portfolio
record_format Article
series Scientific Reports
spelling doaj.art-beed324502c340b2bfb8af51783507d62022-12-21T22:09:44ZengNature PortfolioScientific Reports2045-23222022-03-0112111110.1038/s41598-022-08700-4Systematic and meta-analysis of Mycobacterium avium subsp. paratuberculosis related type 1 and type 2 diabetes mellitusTemitope C. Ekundayo0Ayodeji O. Falade1Bright E. Igere2Chidozie D. Iwu3Mary A. Adewoyin4Tosin A. Olasehinde5Oluwatosin A. Ijabadeniyi6Department of Biotechnology and Food Science, Durban University of Technology, Steve Biko Campus, Health ServicesBiotechnology, Computational Biochemistry and Phytomedicine Research Group, Department of Biochemistry, University of Medical SciencesDepartment of Microbiology and Biotechnology, Western Delta UniversitySchool of Health Systems and Public Health, Faculty of Health Sciences, University of PretoriaDepartment of Biological Sciences, Anchor UniversityNutrition and Toxicology Division, Food Technology Department, Federal Institute of Industrial Research OshodiDepartment of Biotechnology and Food Science, Durban University of Technology, Steve Biko Campus, Health ServicesAbstract Global increase in diabetes (DM) prevalence necessitated the need to establish the association between DM and environmental triggers including MAP (Mycobacterium avium subsp. paratuberculosis) that have been postulated to play a role in DM etiopathology for effective management. The present investigation aimed to assess the odds ratio (OR) presenting the association between MAP and DM. MAP-related DM studies were systematically retrieved from 6 databases until 31 September 2021 according to PRISMA principles for data abstraction. The abstracted dataset was fitted to the fixed-effects (FE) and random-effects (RE) models using the Mantel–Haenszel approach. Sixteen studies involving 2072 participants (1152 DM patients (957 type 1 diabetes mellitus (T1DM) & 195 type 2 diabetes mellitus (T2DM)) and 920 healthy controls) met the inclusion criteria. Results revealed a significant association between anti-MAP antibodies (abs) seroprevalence and T1DM (FE: OR 7.47, 95% CI 5.50–10.14, p value < 0.0001; RE: OR 7.92, 95% CI 4.39–14.31, p < 0.0001) and MAP DNA with T1DM (FE: OR 4.70 (95% CI 3.10–7.13, p value < 0.0001), RE: OR 3.90 (95% CI 0.93–16.38, p value = 0.06)). Both anti-MAP abs and MAP DNA based meta-analyses had medium heterogeneity (I2 = 47.2–61.0%). Meanwhile, no significant association between MAP and T2DM (FE: OR 1.13, 95% CI 0.54–2.37, p value = 0.74; RE: OR 1.19; 95% CI 0.34–4.12, p value = 0.69), its OR magnitude exceeded 1 and prediction interval (0.09–15.29) suggest possibility of association between the duo in the future. The leave-one-out sensitivity analysis depicts a robust meta-analysis in all cases. In conclusion, the study manifests a positive association between MAP and T1DM, highlighting that MAP prevention and environmental control would indubitably revolutionize T1DM management. Also, its projects possible link between MAP and T2DM as more data becomes available. However, it remains elusive whether MAP triggers T1/T2DM or a mere comorbidity in T1/T2DM. Epidemiological activities to fill the global/regional data gaps on MAP-related T1DM and T2DM are advocated in order to assess the burden of MAP-related DM and improve their clinical management.https://doi.org/10.1038/s41598-022-08700-4
spellingShingle Temitope C. Ekundayo
Ayodeji O. Falade
Bright E. Igere
Chidozie D. Iwu
Mary A. Adewoyin
Tosin A. Olasehinde
Oluwatosin A. Ijabadeniyi
Systematic and meta-analysis of Mycobacterium avium subsp. paratuberculosis related type 1 and type 2 diabetes mellitus
Scientific Reports
title Systematic and meta-analysis of Mycobacterium avium subsp. paratuberculosis related type 1 and type 2 diabetes mellitus
title_full Systematic and meta-analysis of Mycobacterium avium subsp. paratuberculosis related type 1 and type 2 diabetes mellitus
title_fullStr Systematic and meta-analysis of Mycobacterium avium subsp. paratuberculosis related type 1 and type 2 diabetes mellitus
title_full_unstemmed Systematic and meta-analysis of Mycobacterium avium subsp. paratuberculosis related type 1 and type 2 diabetes mellitus
title_short Systematic and meta-analysis of Mycobacterium avium subsp. paratuberculosis related type 1 and type 2 diabetes mellitus
title_sort systematic and meta analysis of mycobacterium avium subsp paratuberculosis related type 1 and type 2 diabetes mellitus
url https://doi.org/10.1038/s41598-022-08700-4
work_keys_str_mv AT temitopecekundayo systematicandmetaanalysisofmycobacteriumaviumsubspparatuberculosisrelatedtype1andtype2diabetesmellitus
AT ayodejiofalade systematicandmetaanalysisofmycobacteriumaviumsubspparatuberculosisrelatedtype1andtype2diabetesmellitus
AT brighteigere systematicandmetaanalysisofmycobacteriumaviumsubspparatuberculosisrelatedtype1andtype2diabetesmellitus
AT chidoziediwu systematicandmetaanalysisofmycobacteriumaviumsubspparatuberculosisrelatedtype1andtype2diabetesmellitus
AT maryaadewoyin systematicandmetaanalysisofmycobacteriumaviumsubspparatuberculosisrelatedtype1andtype2diabetesmellitus
AT tosinaolasehinde systematicandmetaanalysisofmycobacteriumaviumsubspparatuberculosisrelatedtype1andtype2diabetesmellitus
AT oluwatosinaijabadeniyi systematicandmetaanalysisofmycobacteriumaviumsubspparatuberculosisrelatedtype1andtype2diabetesmellitus